Oral Contraceptive Pills Market Size and Forecast 2024-2033|Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., Novartis AG, AbbVie Inc

The Oral Contraceptive Pills Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Oral Contraceptive Pills Market:

https://www.thebusinessresearchcompany.com/report/oral-contraceptive-pills-global-market-report

According to The Business Research Company’s Oral Contraceptive Pills Global Market Report 2024, The oral contraceptive pills market size has grown rapidly in recent years. It will grow from $23.66 billion in 2023 to $27.12 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The  growth in the historic period can be attributed to increasing awareness, rising women’s health concerns, government initiatives, changing lifestyles, market expansion.

The oral contraceptive pills market size is expected to see rapid growth in the next few years. It will grow to $47.15 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to growing population, women’s empowerment, rising healthcare expenditure, advancements in healthcare infrastructure, expanding product portfolio. Major trends in the forecast period include focus on minimizing side effects and hormonal disruption, emergence of non-hormonal and natural contraceptive alternatives, shift towards continuous and tailored contraceptive regimens, increasing awareness and education initiatives, rise in female empowerment and involvement in contraceptive choices.

The high incidence of unintended pregnancies is expected to drive the growth of the oral contraceptive pills market over the coming years. An unintended pregnancy is a pregnancy that is always unwanted, such as a pregnancy where no children have been planned. The University of California, San Francisco (UCSF) study shows that the rates of unwanted pregnancy and abortion declined substantially when women received a one-year prescription of oral contraceptives. According to the World Health Organization (WHO), 74 million women living in low-middle-income economies register unplanned pregnancies every year globally. The WHO’s research noticed that 4,794 women had unplanned pregnancies after they had discontinued using contraceptives. Therefore, the need to avoid unintended pregnancies drives the growth of the oral contraceptive pills market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=3900&type=smp

The oral contraceptive pills market covered in this report is segmented –

1) By Type: Combination, Progestin Only, Other Types

2) By Category: Generic, Branded

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channel, Public Channel And NGO, Other Distribution Channel

Major institutes and companies operating in the oral contraceptive pill sector are focusing on developing innovative solutions for oral contraceptive pills. For instance, in July 2022, HRA Pharma, a France based innovative healthcare company, developed an over-the-counter birth control pill called Opill. HRA Pharma has applied to the Food and Drug Administration in the United States. Opil is a progestin-based contraceptive that helps people access contraception without facing any difficulty.

The oral contraceptive pills market report table of contents includes:

1. Executive Summary

2. Oral Contraceptive Pills Market Characteristics

3. Oral Contraceptive Pills Market Trends And Strategies

4. Oral Contraceptive Pills Market – Macro Economic Scenario

5. Global Oral Contraceptive Pills Market Size and Growth

.

.

.

26. South America Oral Contraceptive Pills Market

27. Brazil Oral Contraceptive Pills Market

28. Middle East Oral Contraceptive Pills Market

29. Africa Oral Contraceptive Pills Market

30. Oral Contraceptive Pills Market Competitive Landscape And Company Profiles

Top Major Players:

  • Pfizer Inc.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • AbbVie Inc

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model